• Users Online: 250
  • Print this page
  • Email this page
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
  Most cited articles *

 
 
  Archives   Most popular articles   Most cited articles
 
Show all abstracts  Show selected abstracts  Export selected to
  Cited Viewed PDF
EDITORIALS
Improving outcomes in Rhabdomyosarcoma-The way ahead
Badira Cheriyalinkal Parambil, Subramaniam Ramanathan
January-June 2019, 2(1):69-71
DOI:10.4103/CRST.CRST_47_19  
  5 904 115
GERIATRIC ONCOLOGY SECTION
Survey for geriatric assessment in practicing oncologists in India
Vanita Noronha, Vikas Talreja, Amit Joshi, Vijay Patil, Kumar Prabhash
July-December 2019, 2(2):232-236
DOI:10.4103/CRST.CRST_99_19  
  5 1,481 92
REVIEW ARTICLES
Repurposing valproate to prevent acute respiratory distress syndrome/acute lung injury in COVID-19: A review of immunomodulatory action
Prabhat Bhargava, Pankaj Panda, Vikas Ostwal, Anant Ramaswamy
April 2020, 3(5):65-70
DOI:10.4103/CRST.CRST_156_20  
  5 2,699 190
INTERESTING ONGOING TRIALS
Induction therapy in newly diagnosed multiple myeloma: Current research scenario and questions for the future
Bhausaheb Bagal, Avinash Bonda
January-June 2019, 2(1):76-82
DOI:10.4103/CRST.CRST_42_19  
  4 1,421 140
ORIGINAL ARTICLES
Clinical–radiological features of methotrexate-induced subacute leukoencephalopathy in patients with acute lymphoblastic leukemia: 'Panda eye sign' on diffusion weighted-magnetic resonance imaging
Abhishek Mahajan, Hasmukh Jain, Vijai Simha, Tanvi Vaidya, GV Santhosh Kumar, Anurag Gupta, Bhausaheb Bagal, Manju Sengar
January-June 2019, 2(1):28-33
DOI:10.4103/CRST.CRST_22_19  
  4 2,795 141
EDITORIALS
Challenges in the management of intraventricular tumors in the current era
Rahul Krishnatry
January-June 2019, 2(1):72-73
DOI:10.4103/CRST.CRST_39_19  
  3 775 93
LETTERS TO EDITOR
Osimertinib in G719A mutated non-small cell lung cancer with leptomeningeal metastases
Avinash Pandey, Anjana Singh, Shivkant Singh, Amit Kumar
January-June 2019, 2(1):121-123
DOI:10.4103/CRST.CRST_27_19  
  3 1,704 136
MUSINGS
COPING with CORONA: A developing country perspective on managing children with cancer during COVID-19 pandemic
Megha Saroha, Nirmalya Roy Moulik
April 2020, 3(5):97-101
DOI:10.4103/CRST.CRST_131_20  
  3 1,334 188
REVIEW ARTICLES
COVID-19 and head and neck cancer treatment
Vijay Patil, Vanita Noronha, Pankaj Chaturvedi, Kaustav Talapatra, Amit Joshi, Nandini Menon, Durgatosh Pandey, Kumar Prabhash
April 2020, 3(5):15-28
DOI:10.4103/CRST.CRST_135_20  
  3 3,687 363
EDITORIALS
Head-and-neck dermatofibrosarcoma protuberans: Where does imatinib 'fit in'?
Avinash Vijaykumar Pandey, Anjana Singh
January-June 2019, 2(1):74-75
DOI:10.4103/CRST.CRST_46_19  
  2 699 75
Health-related quality of life: Is it a missing feature in the Indian cancer setting?
Naveen Salins
July-December 2019, 2(2):213-214
DOI:10.4103/CRST.CRST_91_19  
  2 866 76
LETTERS TO EDITOR
Head-and-neck dermatofibrosarcoma protuberans: Scooping out data even in dearth of evidence
Akhil Kapoor, Amit Kumar
July-December 2019, 2(2):256-257
DOI:10.4103/CRST.CRST_70_19  
  2 493 44
Panda eye sign on diffusion weighted-MRI for the diagnosis of methotrexate-induced subacute leukoencephalopathy
Nidhi Tandon, Mansi Khanderia, Santhosh Kumar Devadas
July-December 2019, 2(2):263-264
DOI:10.4103/CRST.CRST_80_19  
  2 509 41
Head-and-neck cancer management in the COVID-19 era: Practice recommendations
Arvind Krishnamurthy
April - June 2020, 3(2):323-324
DOI:10.4103/CRST.CRST_167_20  
  2 468 71
Hematological malignancies in the time of COVID-19
Arun Chandrasekharan, KP Sreelesh, KV Gangadharan
April - June 2020, 3(2):343-344
DOI:10.4103/CRST.CRST_175_20  
  2 349 57
COVID-19 in hematological malignancies
Bhausaheb Bagal, Pritesh Munot, Lingaraj Nayak
April - June 2020, 3(2):345-345
DOI:10.4103/CRST.CRST_182_20  
  2 431 69
Immunotherapy during the COVID-19 pandemic
Vinay Mathew Thomas, Aju Mathew
April 2020, 3(5):149-150
DOI:10.4103/CRST.CRST_129_20  
  2 673 110
MUSINGS
Palliative care for advanced cancer patients in the COVID-19 pandemic: Challenges and adaptations
Pankaj Singhai, Krithika S Rao, Seema Rajesh Rao, Naveen Salins
April 2020, 3(5):127-132
DOI:10.4103/CRST.CRST_130_20  
  2 2,689 397
Social issues faced by cancer patients during the coronavirus (COVID-19) pandemic
Nirjari Viren Dalal
April 2020, 3(5):141-144
DOI:10.4103/CRST.CRST_109_20  
  2 2,914 274
ORIGINAL ARTICLES
Outcomes and impact of minimal residual disease (MRD) in pediatric, adolescent and young adults (AYA) with acute lymphoblastic leukemia treated with modified MCP 841 protocol
Avinash Pandey, Shivali Ahlawat, Anjana Singh, Shivkant Singh, Krishna Murari, Raj Aryan
April - June 2020, 3(2):183-191
DOI:10.4103/CRST.CRST_85_20  
  2 1,650 158
Determination of ROS1 positivity by immunohistochemistry in a multicentric cohort of 426 non-small-cell lung cancer cases in India
Jugnu Jain, Deepthi Chinta, Umeshnandan B Jayaraman, Neha Pathak, Manpreet Kaur, Soma Chatterjee, Meenakshi Swain, Vijay Anand Reddy
January-June 2019, 2(1):16-20
DOI:10.4103/CRST.CRST_12_19  
  2 2,152 185
REVIEW ARTICLES
Epidermal growth factor receptor-mutated non-small-cell lung cancer: A primer on contemporary management
Akhil Rajendra, Vanita Noronha, Amit Joshi, Vijay Maruti Patil, Nandini Menon, Kumar Prabhash
January-June 2019, 2(1):36-53
DOI:10.4103/CRST.CRST_51_19  
  2 3,502 248
STATISTICAL RESOURCE
Basics of statistics-3: Sample size calculation – (i)
HS Darling
April - June 2020, 3(2):317-322
DOI:10.4103/CRST.CRST_100_20  
  2 1,332 183
Testing and interpreting assumptions of COX regression analysis
Sampada Dessai, Vijay Patil
January-June 2019, 2(1):108-111
DOI:10.4103/CRST.CRST_40_19  
  2 5,280 536
SYSTEMATIC REVIEW
Depth of tumor infiltration as a prognosticator in pT1-2 cN0 oral squamous cell carcinoma thereby need for elective neck dissection – A meta-analysis
Mohammad Akheel, Rinku K George, Amit Jain, Qutubuddin Chahwala, Ashmi Wadhwania
January-June 2019, 2(1):61-65
DOI:10.4103/CRST.CRST_24_19  
  2 1,065 117
* Source: CrossRef